Michael S. Harper - Concepedia

Author

Michael S. Harper

University of Colorado Denver ORCID

Also Known As

Harper, Michael S., M Harper, Michael S Harper, Michael S. Harper

Publications

506

Citations

H-Index

Concepts

All Affiliations

University of Colorado Denver University of Duisburg-Essen University of Colorado Anschutz Medical Campus National Institute of Allergy and Infectious Diseases

About

Michael S. Harper is an author at University of Colorado Denver specializing in medicine, immunology, and viral immunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	191
2	Immunology	5	5	191
3	Cell Biology	3	3	152
4	Epidemiology	1	1	28
5	Microbiology	1	1	37

Michael S. Harper

Publications

462

Citations

H-Index

Page 1

	Year	Citations
Interferon Alpha Subtype-Specific Suppression of HIV-1 Infection<i>In Vivo</i> Kerry J. Lavender, Kathrin Gibbert, Karin E. Peterson, Journal of Virology	2016	119
Interferon-α Subtypes in an Ex Vivo Model of Acute HIV-1 Infection: Expression, Potency and Effector Mechanisms Michael S. Harper, Kejun Guo, Kathrin Gibbert, PLoS Pathogens ImmunodeficienciesInnate Immune SystemImmunologyImmune RegulationImmunodominance	2015	96
Enhancement of HIV-1 infection and intestinal CD4+ T cell depletion ex vivo by gut microbes altered during chronic HIV-1 infection Stephanie M. Dillon, Eric Lee, Andrew M. Donovan, Retrovirology	2016	63
The transcriptome of HIV-1 infected intestinal CD4+ T cells exposed to enteric bacteria Alyson Yoder, Kejun Guo, Stephanie M. Dillon, PLoS Pathogens InflammationMucosal Hiv-1 PathogenesisMucosal ImmunologyHuman RetrovirusPathogenesis	2017	37
Breaching peripheral tolerance promotes the production of HIV-1–neutralizing antibodies Kristin Schroeder, Amanda Agazio, Pamela Strauch, The Journal of Experimental Medicine	2017	33
Innate immune signatures to a partially-efficacious HIV vaccine predict correlates of HIV-1 infection risk Erica Andersen‐Nissen, Andrew Fioré-Gartland, Lamar Ballweber-Fleming, PLoS Pathogens Adaptive Immune SystemInnate Immune SignaturesImmunologyHiv-1 Vaccine RegimensCd4 T Cell Responses	2021	28
IFN-α Treatment Inhibits Acute Friend Retrovirus Replication Primarily through the Antiviral Effector Molecule Apobec3 Michael S. Harper, Bradley S. Barrett, Diana S. Smith, The Journal of Immunology	2013	21
Reassessment of murine APOBEC1 as a retrovirus restriction factor in vivo Bradley S. Barrett, Kejun Guo, Michael S. Harper, Virology Murine Apobec1Human RetrovirusPathogenesisImmunologyAntiviral Response	2014	19
Lymphadenopathy in HIV (HTLV-III/LAV) infected subjects: the role of virus and follicular dendritic cells. Peter Biberfeld, Anna Porwit, Gunnel Biberfeld, PubMed	1988	18
Friend retrovirus drives cytotoxic effectors through Toll-like receptor 3 Kathrin Gibbert, Sandra Francois, Anna M. Sigmund, Retrovirology	2014	17

Page 1